Arcadis Future Growth
Future criteria checks 3/6
Arcadis's revenue is forecast to decline at 0.3% per annum while its annual earnings are expected to grow at 14.5% per year. EPS is expected to grow by 15.2% per annum. Return on equity is forecast to be 21.9% in 3 years.
Key information
14.5%
Earnings growth rate
15.25%
EPS growth rate
Professional Services earnings growth | 12.7% |
Revenue growth rate | -0.3% |
Future return on equity | 21.88% |
Analyst coverage | Good |
Last updated | 12 Oct 2025 |
Recent future growth updates
Recent updates
Arcadis (AMS:ARCAD) Has A Pretty Healthy Balance Sheet
Sep 27Is Now An Opportune Moment To Examine Arcadis NV (AMS:ARCAD)?
Aug 25The Price Is Right For Arcadis NV (AMS:ARCAD)
Aug 01Arcadis' (AMS:ARCAD) Returns On Capital Are Heading Higher
Jun 30Should You Be Adding Arcadis (AMS:ARCAD) To Your Watchlist Today?
Jun 18With Arcadis NV (AMS:ARCAD) It Looks Like You'll Get What You Pay For
Apr 21What Is Arcadis NV's (AMS:ARCAD) Share Price Doing?
Mar 26Does Arcadis (AMS:ARCAD) Have A Healthy Balance Sheet?
Feb 28Climate Adaptation And Energy Projects Will Shape Future Market Success
Focus on climate strategies and energy projects increases revenue and market position, driven by infrastructure resilience and rising energy demands.Arcadis (AMS:ARCAD) Shareholders Will Want The ROCE Trajectory To Continue
Jan 09Arcadis NV's (AMS:ARCAD) Share Price Matching Investor Opinion
Dec 26Here's Why Arcadis (AMS:ARCAD) Has Caught The Eye Of Investors
Dec 14At €64.70, Is Arcadis NV (AMS:ARCAD) Worth Looking At Closely?
Nov 02Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2027 | 4,320 | 348 | 375 | 465 | 2 |
12/31/2026 | 4,156 | 310 | 308 | 424 | 3 |
12/31/2025 | 3,916 | 247 | 209 | 326 | 3 |
6/30/2025 | 4,936 | 238 | 252 | 289 | N/A |
3/31/2025 | 4,966 | 241 | 279 | 320 | N/A |
12/31/2024 | 4,995 | 243 | 305 | 350 | N/A |
9/30/2024 | 5,017 | 223 | 311 | 354 | N/A |
6/30/2024 | 5,038 | 203 | 316 | 358 | N/A |
3/31/2024 | 5,021 | 182 | 292 | 334 | N/A |
12/31/2023 | 5,003 | 160 | 268 | 309 | N/A |
9/30/2023 | 4,831 | 137 | 196 | 238 | N/A |
6/30/2023 | 4,659 | 114 | 124 | 168 | N/A |
3/31/2023 | 4,344 | 123 | 184 | 226 | N/A |
12/31/2022 | 4,029 | 132 | 244 | 284 | N/A |
9/30/2022 | 3,797 | 154 | 247 | 285 | N/A |
6/30/2022 | 3,566 | 177 | 251 | 285 | N/A |
3/31/2022 | 3,472 | 173 | 273 | 307 | N/A |
12/31/2021 | 3,378 | 168 | 295 | 329 | N/A |
9/30/2021 | 3,319 | 101 | 321 | 351 | N/A |
6/30/2021 | 3,260 | 34 | 348 | 372 | N/A |
3/31/2021 | 3,282 | 26 | 376 | 400 | N/A |
12/31/2020 | 3,303 | 19 | 404 | 429 | N/A |
9/30/2020 | 3,386 | 30 | 326 | 367 | N/A |
6/30/2020 | 3,469 | 38 | 248 | 294 | N/A |
3/31/2020 | 3,471 | 25 | 209 | 256 | N/A |
12/31/2019 | 3,473 | 12 | 169 | 218 | N/A |
9/30/2019 | 3,425 | -7 | 183 | 238 | N/A |
6/30/2019 | 3,377 | -26 | 196 | 259 | N/A |
3/31/2019 | 3,316 | -26 | N/A | 237 | N/A |
12/31/2018 | 3,256 | -27 | N/A | 214 | N/A |
9/30/2018 | 3,206 | 23 | N/A | 194 | N/A |
6/30/2018 | 3,156 | 72 | N/A | 174 | N/A |
3/31/2018 | 3,188 | 72 | N/A | 163 | N/A |
12/31/2017 | 3,219 | 71 | N/A | 151 | N/A |
9/30/2017 | 3,259 | 64 | N/A | 161 | N/A |
6/30/2017 | 3,299 | 58 | N/A | 171 | N/A |
3/31/2017 | 3,314 | 61 | N/A | 155 | N/A |
12/31/2016 | 3,329 | 64 | N/A | 139 | N/A |
9/30/2016 | 3,366 | 81 | N/A | 141 | N/A |
6/30/2016 | 3,404 | 98 | N/A | 142 | N/A |
3/31/2016 | 3,412 | 98 | N/A | 157 | N/A |
12/31/2015 | 3,419 | 99 | N/A | 171 | N/A |
9/30/2015 | 3,275 | 93 | N/A | 151 | N/A |
6/30/2015 | 3,130 | 86 | N/A | 132 | N/A |
3/31/2015 | 2,883 | 89 | N/A | 136 | N/A |
12/31/2014 | 2,635 | 92 | N/A | 139 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ARCAD's forecast earnings growth (14.5% per year) is above the savings rate (1.6%).
Earnings vs Market: ARCAD's earnings (14.5% per year) are forecast to grow faster than the Dutch market (11% per year).
High Growth Earnings: ARCAD's earnings are forecast to grow, but not significantly.
Revenue vs Market: ARCAD's revenue is expected to decline over the next 3 years (-0.3% per year).
High Growth Revenue: ARCAD's revenue is forecast to decline over the next 3 years (-0.3% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ARCAD's Return on Equity is forecast to be high in 3 years time (21.9%)
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/10/14 17:40 |
End of Day Share Price | 2025/10/14 00:00 |
Earnings | 2025/06/30 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Arcadis NV is covered by 11 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Himanshu Agarwal | BofA Global Research |
Luuk Van Beek | Degroof Petercam |
Quirijn Mulder | ING Groep NV |